12:00 AM
Feb 25, 2013
 |  BC Week In Review  |  Company News  |  Other News

Gilead, Teva infectious news

Gilead and Teva settled a March 2010 patent suit claiming Teva's ANDA for a generic version of HIV and HBV drug Viread tenofovir disoproxil fumarate infringes Gilead's U.S. Patent Nos....

Read the full 136 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >